Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Tissue Banking and Analysis Center (TBAC) is a specialized biospecimen and molecular analysis provider that operates as a subsidiary of Caris Life Sciences (formerly Caris MPI). Originally established as a joint venture between the Molecular Profiling Institute and US Oncology, the center provides comprehensive services including tissue procurement, storage, tracking, and high-throughput molecular profiling. TBAC supports pharmaceutical companies and academic researchers in clinical trial design and biomarker discovery, particularly in the field of oncology. By leveraging genomic and proteomic analysis, the center facilitates the selection of trial participants and the development of personalized therapeutic strategies. Headquartered in Phoenix, Arizona, TBAC remains a critical component of Caris's precision medicine infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tissue Banking and Analysis Center.